62 results
8-K
EX-99.1
RVMD
Revolution Medicines Inc
9 Jan 24
Results of Operations and Financial Condition
2:15pm
contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective
425
o5fzxlqtgnh270ngeb
23 Oct 23
Business combination disclosure
6:13am
8-K
EX-99.1
uy7p92a
23 Oct 23
Regulation FD Disclosure
6:11am
DEFM14A
c6eq22l sraa36d
29 Sep 23
Proxy related to merger
4:19pm
424B3
mk4ihtnnnc jyk7
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
gc0 uq9za2yg8xa
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
S-4
1gzvyb
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
425
zr6deug208hdd06dqjq
1 Aug 23
Business combination disclosure
5:24pm
425
plyw2lns6f23 x9i
1 Aug 23
Business combination disclosure
5:22pm
425
j8moypff1bj9g 23
1 Aug 23
Business combination disclosure
5:11pm
425
5tecp
1 Aug 23
Business combination disclosure
7:15am
8-K
EX-2.1
nte1wrn8kyf
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:10am
8-K
EX-99.1
6wrrgkq
8 May 23
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
4:04pm